CD26 a cancer stem cell marker and therapeutic target.

Davies, Samuel; Beckenkamp, Aline; Buffon, Andréia

Davies, Samuel; Beckenkamp, Aline; Buffon, Andréia.

Affiliation

Davies S; Laboratory of Biochemical and Cytological Analysis, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Beckenkamp A; Laboratory of Biochemical and Cytological Analysis, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Buffon A; Laboratory of Biochemical and Cytological Analysis, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: andreia.buffon@ufrgs.br.

Biomed Pharmacother ; 71: 135-8, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25960228

Subject(s)

Biomarkers, Tumor/metabolism; Dipeptidyl Peptidase 4/metabolism; Molecular Targeted Therapy; Neoplastic Stem Cells/metabolism; Humans; Neoplastic Stem Cells/pathology

Key words

CD26; CSC marker; Cancer stem cells; Indifferentiation marker; Therapeutic target

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Biomarkers, Tumor / Dipeptidyl Peptidase 4 / Molecular Targeted Therapy Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biomed Pharmacother Year: 2015 Document type: Article Affiliation country: Brazil Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google